Matthew Brams - 09 Mar 2026 Form 4 Insider Report for Cingulate Inc. (CING)

Role
EVP and Chief Medical Officer
Signature
/s/ Shane J. Schaffer, Attorney-in-Fact
Issuer symbol
CING
Transactions as of
09 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 20:13:25 UTC
Previous filing
10 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Brams Matthew EVP and Chief Medical Officer 1901 W. 47TH PLACE, KANSAS CITY /s/ Shane J. Schaffer, Attorney-in-Fact 11 Mar 2026 0001884361

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CING Common Stock Award +4,526 +97% $0.000000* 9,182 09 Mar 2026 Direct F1
transaction CING Common Stock Tax liability -1,025 -11% $0.000000* 8,157 09 Mar 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock were granted pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended, for a portion of the Reporting Person's 2025 bonus.
F2 Shares otherwise issuable were withheld to satisfy the Reporting Person's tax obligations on the grant described in footnote 1 above.